Effects of Epidermal Growth Factor Receptor Inhibitor Genistein on Proliferative Cholangitis in Rats

Journal of Surgical Research

Volumn 162, Issue 1, 2010, Pages 59-67

  Jiang, Li ^a   Jiang, Li Sheng ^a   Yan, Lu Nan ^a   Li, Fu Yu ^a   Wang, Wei ^a   Cheng, Nan Sheng ^a   Wen, Tian Fu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

biliary stricture; epidermal growth factor receptor; epidermal growth factor receptor inhibitor; genistein; hepatolithiasis; proliferative cholangitis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GENISTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE DUCT DILATATION; BILE DUCT OBSTRUCTION; BILE DUCT STONE; CELL PROLIFERATION; CHOLANGITIS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG MEGADOSE; EPITHELIUM CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE STRUCTURE;

ANIMALS; BILE DUCTS; CHOLANGITIS; COLORING AGENTS; GENISTEIN; IMMUNOHISTOCHEMISTRY; MALE; PERIODIC ACID-SCHIFF REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953285572     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.04.048     Document Type: Article

References (37)

1. Cheung M.T., and Kwok P.C. Liver resection for intrahepatic stones. Arch Surg 140 (2005) 993
2. Chen D.W., Tung-Ping Poon R., Liu C.L., et al. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery 135 (2004) 386
3. Park S.M., Choi J.W., Kim S.T., et al. Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel. J Hepatobiliary Pancreat Surg 10 (2003) 176
4. Li F., Cheng J., He S., et al. The practical value of applying chemical biliary duct embolization to chemical hepatectomy for treatment of hepatolithiasis. J Surg Res 127 (2005) 131
5. Yoshida M., Yamamoto N., Nitta T., et al. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide. J Surg Res 102 (2002) 95
6. Shoda J., Ueda T., Kawamoto T., et al. Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiologic significance for cholangitis. Clin Gastroenterol Hepatol 1 (2003) 285
7. Kim H.J., Lee S.K., Kim M.H., et al. Cystic fibrosis transmembrane conductance regulators (CFTR) in biliary epithelium of patients with hepatolithiasis. Dig Dis Sci 47 (2002) 1758
8. Jan Y.Y., Chen M.F., Wang C.S., et al. Surgical treatment of hepatolithiasis: Long-term results. Surgery 120 (1996) 509
9. Kim H.J., Kim J.S., Kang C.D., et al. Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma. Korean J Gastroenterol 45 (2005) 52
10. Napoli J., Prentice D., Niinami C., et al. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 26 (1997) 624
11. Yoon J.H., Werneburg N.W., Higuchi H., et al. Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res 62 (2002) 6500
12. Chacko B.K., Chandler R.T., Mundhekar A., et al. Revealing anti-inflammatory mechanisms of soy isoflavones by flow: Modulation of leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 289 (2005) 908
13. Yang E.B., Wei L., Zhang K., et al. Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase. J Biochem 139 (2006) 495
14. Moore A.B., Castro L., Yu L., et al. Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration. Hum Reprod 22 (2007) 2623
15. Yu J.Y., Lee J.J., Lim Y., et al. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J Pharmacol Sci 107 (2008) 90
16. Long H.C., Wang Z.L., Xiao B.R., et al. Effect of tyrosine kinase inhibitors on airway remodeling in bronchial asthma. Sichuan Da Xue Xue Bao Yi Xue Ban 36 (2005) 39
17. Vantyghem S.A., Wilson S.M., Postenka C.O., Al-Katib W., Tuck A.B., and Chambers A.F. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 65 (2005) 3396
18. Katz J., Blake E., Medrano T.A., et al. Isoflavones and gamma irradiation inhibit cell growth in human salivary gland cells. Cancer Lett 270 (2008) 87-94
19. Uchiyama K., Onishi H., Tani M., et al. Indication and procedure for treatment of hepatolithiasis. Arch Surg 137 (2002) 149
20. Cheng Y.F., Lee T.Y., Sheen-Chen S.M., et al. Treatment of complicated hepatolithiasis with intrahepatic biliary stricture by ductal dilatation and stenting: Long-term results. World J Surg 24 (2000) 712
21. Cheung M.T., Wai S.H., and Kwok P.C. Percutaneous transhepatic choledochoscopic removal of intrahepatic stones. Br J Surg 90 (2003) 1409
22. Li S.Q., Liang L.J., Peng B.G., et al. Hepaticojejunostomy for hepatolithiasis: A critical appraisal. World J Gastroenterol 12 (2006) 4170
23. Baselga J. Targeting the epidermal growth factor receptor: A clinical reality. J Clin Oncol 19 (2001) 41
24. Harari P.M., Allen G.W., and Bonner J.A. Biology of interactions: Anti-epidermal growth factor receptor agents. J Clin Oncol 25 (2007) 4057
25. Ciardiello F. Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol 1 (2005) 221
26. Arteaga C.L. The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 19 (2001) 32
27. Ohta T., Elnemr A., Yasui T., et al. Expression of nerve growth factor in hepatolithiasis. Liver 19 (1999) 489
28. Sheen-Chen S., Chen W., Eng H., et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 28 (2000) 298
29. Chang W.T., Lee K.T., Wang S.R., et al. Bacteriology and antimicrobial susceptibility in biliary tract disease: An audit of 10-year's experience. Kaohsiung J Med Sci 18 (2002) 221
30. Burgel P.R., and Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59 (2004) 992
31. Nadel J.A., and Burgel P.R. The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 1 (2001) 254
32. Lee K.T., and Liu T.S. Mucin gene expression in gallbladder epithelium with black pigment stone ascertained by in situ hybridization. Kaohsiung J Med Sci 17 (2001) 517
33. Grases F., Garcia-Ferragut L., Costa-Bauzá A., et al. Study of the effects of different substances on the early stages of papillary stone formation. Nephron 73 (1996) 561
34. Chang H.J., Suh J.I., and Kwon S.Y. Gallstone formation and gallbladder mucosal changes in mice fed a lithogenic diet. J Korean Med Sci 14 (1999) 286
35. Zen Y., Harada K., Sasaki M., et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: Possible key phenomenon of hepatolithiasis. Am J Pathol 161 (2002) 1475
36. Hwang J.H., Yoon Y.B., Kim Y.T., et al. Risk factors for recurrent cholangitis after initial hepatolithiasis treatment. J Clin Gastroenterol 38 (2004) 364
37. Zhou Y.M., Yin Z.F., Yang J.M., et al. Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World J Gastroenterol 14 (2008) 632